Juvenile Idiopathic Arthritis: Diagnosis and Treatment Gabriella GiancaneAlessandro ConsolaroAngelo Ravelli Review Open access 12 August 2016 Pages: 187 - 207
An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus Amit ThakralMarisa S. Klein-Gitelman Review Open access 30 September 2016 Pages: 209 - 219
Review of Osteosarcoma and Current Management Ryan A. DurfeeMaryam MohammedHue H. Luu Review Open access 19 October 2016 Pages: 221 - 243
Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe Kunal ThakurAnna BibergerMourad Farouk Rezk Original Research Open access 05 November 2016 Pages: 245 - 256
Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis Peter NashJohan VanhoofAlfred Cividino Original Research Open access 18 August 2016 Pages: 257 - 270
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study Andreas SchwartingJohann O. SchroederHeike Carnarius Original Research Open access 01 November 2016 Pages: 271 - 290
Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study Alan KivitzThomas WallaceMargaret Michalska Original Research Open access 24 September 2016 Pages: 291 - 304
Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US Vibeke StrandElaine HusniArijit Ganguli Original Research Open access 15 September 2016 Pages: 305 - 322
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis Keith A. BettsJenny GriffithArijit Ganguli Original Research Open access 25 July 2016 Pages: 323 - 336
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources Sharareh MonemiErhan BerberAttila Pethoe-Schramm Original Research Open access 15 July 2016 Pages: 337 - 352
Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil Marina Amaral de Ávila MachadoFelipe FerreFrancisco de Assis Acurcio Original Research Open access 11 July 2016 Pages: 353 - 361
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis Philip MeaseIain B. McInnes Erratum Open access 25 July 2016 Pages: 363 - 363
Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe Kunal ThakurAnna BibergerMourad Farouk Rezk Erratum Open access 29 September 2016 Pages: 365 - 365
